S&P/ASX 200 (XJO) today – HLS, CSL, IGO & AMZN stock in focus
Drew Meredith, CFP
December 10, 2020
The S&P/ASX 200 (ASX: XJO) is expected to open slightly
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The S&P/ASX 200 (ASX: XJO) is expected to open slightly
The CSL Limited (ASX:CSL) share price could be in danger,
The S&P/ASX 200 (INDEXASX:XJO) is set to rise when (or
CSL Limited (ASX:CSL) is in the news this morning after
The S&P/ASX 200 (ASX: XJO) is expected to open higher
The S&P/ASX 200 (INDEXASX:XJO) is expected to follow a strong
The S&P/ASX 200 (INDEXASX:XJO) is expected to slide when the
The CSL Limited (ASX:CSL) share price is up after the
CSL Limited (ASX:CSL) has continued to be in the top
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
